ea0085p40 | Obesity 1 | BSPED2022
Gubaeva Diliara
, Nabwera Helen
, Benson Cathryn
, Senniappan Senthil
Introduction: Up to 70% of adults living with human immunodeficiency virus (HIV) have excessive weight due to side effects of antiretroviral therapy (ART). Liraglutide is a licenced GLP-1 receptor agonist for the treatment of obesity in adolescents. However, there are no studies on effectiveness and safety of GLP-1 receptor agonists in patients on ART as these patients are excluded from most of the clinical trials. Herein, we present a teenage girl with HIV who developed throm...